Quick Answer
KALA BIO, Inc. reported Common Stock Shares Outstanding of 6.09 million shares for the year ending 2024.
- KALA BIO, Inc. showed an increase of +120.7% in Common Stock Shares Outstanding from 2023 to 2024.
- This data is from KALA BIO, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
- XBRL data for this metric is available from 2016 to 2024 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2017: 1.18 million shares | Q3 2017: 24.35 million shares | Q1 2018: 24.56 million shares | Q2 2018: 24.59 million shares | Q3 2018: 24.65 million shares | Q1 2019: 33.88 million shares | Q2 2019: 33.88 million shares | Q3 2019: 34.54 million shares | Q1 2020: 54.59 million shares | Q2 2020: 55.83 million shares | Q3 2020: 56.06 million shares | Q1 2021: 63.81 million shares | Q2 2021: 64.77 million shares | Q3 2021: 65.09 million shares | Q1 2022: 72.59 million shares | Q2 2022: 72.67 million shares | Q3 2022: 1.48 million shares | Q1 2023: 2.31 million shares | Q2 2023: 2.54 million shares | Q3 2023: 2.69 million shares | Q1 2024: 2.82 million shares | Q2 2024: 4.60 million shares | Q3 2024: 4.61 million shares | Q4 2024: 6.09 million shares | Q1 2025: 6.45 million shares | Q2 2025: 6.68 million shares | Q3 2025: 7.43 million shares.
- Over the full 10 years of available data (2016 to 2024), KALA BIO, Inc.'s Common Stock Shares Outstanding has grown by 415.6%.
- Historical annual values: Fiscal year 2024: 6.09 million shares | Fiscal year 2023: 2.76 million shares | Fiscal year 2022: 1.71 million shares | Fiscal year 2022: 1 shares | Fiscal year 2021: 1.32 million shares | Fiscal year 2020: 58.92 million shares | Fiscal year 2019: 36.09 million shares | Fiscal year 2018: 33.86 million shares | Fiscal year 2017: 24.54 million shares | Fiscal year 2016: 1.18 million shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: